FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  2. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  3. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  4. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  7. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  8. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  9. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  10. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  11. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  12. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  13. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  14. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  15. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  16. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  17. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  18. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  19. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  20. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  21. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  22. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  23. Zhu H, et al. 2018. Elife. 7:. PubMed
  24. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  25. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  26. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  27. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  28. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  29. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  30. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  31. Liu X, et al. 2020. Nature. . PubMed
  32. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  33. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  34. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  35. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  36. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  37. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  38. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  39. Saito S, et al. 2020. Nutrients. 12:. PubMed
  40. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  41. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  42. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  43. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  44. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  45. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  46. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  47. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  48. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  49. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  50. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  51. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  52. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  53. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  54. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  55. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  56. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  57. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  58. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  59. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  60. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  61. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  62. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  63. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  64. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  65. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  66. Plein A, et al. 2018. Nature. 562:223. PubMed
  67. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  68. Green DP, et al. 2019. Neuron. 101:412. PubMed
  69. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  70. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  71. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  72. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  73. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  74. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  75. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  76. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  77. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  78. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  79. Zhang X, et al. 2022. Cells. 11:. PubMed
  80. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  81. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  82. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  83. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  84. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  85. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  86. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  87. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  88. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  89. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  90. Li J, et al. 2020. Elife. 9:00. PubMed
  91. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  92. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  93. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  94. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  95. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  96. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  97. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  98. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  99. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  100. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  101. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  102. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  103. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  104. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  105. Wan X, et al. 2018. Nature. 560:107. PubMed
  106. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  107. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  108. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  109. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  110. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  111. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  112. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  113. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  114. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  115. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  116. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  117. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  118. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  119. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  120. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  121. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  122. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  123. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  124. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  125. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  126. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  127. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  128. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  129. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  130. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  131. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  132. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  133. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  134. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  135. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  136. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  137. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  138. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  139. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  140. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  141. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  142. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  143. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  144. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  145. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  146. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  147. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  148. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  149. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  150. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  151. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  152. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  153. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  154. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  155. Long JT, et al. 2022. Elife. 11:. PubMed
  156. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  157. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  158. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  159. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  160. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  161. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  162. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  163. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  164. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  165. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  166. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  167. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  168. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  169. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  170. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  171. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  172. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  173. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  174. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  175. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  176. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  177. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  178. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  179. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  180. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  181. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  182. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  183. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  184. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  185. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  186. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  187. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  188. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  189. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  190. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  191. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  192. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  193. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  194. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  195. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  196. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  197. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  198. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  199. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  200. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  201. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  202. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  203. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  204. Sheng J, et al. 2021. eLife. 10:00. PubMed
  205. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  206. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  207. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  208. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  209. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  210. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  211. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  212. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  213. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  214. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  215. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  216. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  217. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  218. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  219. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  220. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  221. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  222. Dingler FA, et al. 2020. Mol Cell. . PubMed
  223. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  224. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  225. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  226. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  227. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  228. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  229. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  230. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  231. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  232. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  233. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC, IHC-F, CyTOF®, IP, CMCD, IHC, WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC, SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC, ICC, IHC, 3D IHC, SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC, SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F, FC, 3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC, SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC, CyTOF®, IP, CMCD, IHC, WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD45

  • Biotin anti-mouse CD45

  • FITC anti-mouse CD45

  • PE anti-mouse CD45

  • PE/Cyanine5 anti-mouse CD45

  • Purified anti-mouse CD45

  • PE/Cyanine7 anti-mouse CD45

  • APC/Cyanine7 anti-mouse CD45

  • Alexa Fluor® 488 anti-mouse CD45

  • Alexa Fluor® 647 anti-mouse CD45

  • Pacific Blue™ anti-mouse CD45

  • Alexa Fluor® 700 anti-mouse CD45

  • PerCP/Cyanine5.5 anti-mouse CD45

  • PerCP anti-mouse CD45

  • Alexa Fluor® 594 anti-mouse CD45

  • Brilliant Violet 421™ anti-mouse CD45

  • Brilliant Violet 570™ anti-mouse CD45

  • Brilliant Violet 510™ anti-mouse CD45

  • Brilliant Violet 605™ anti-mouse CD45

  • Purified anti-mouse CD45 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45

  • Brilliant Violet 711™ anti-mouse CD45

  • Brilliant Violet 785™ anti-mouse CD45

  • Brilliant Violet 650™ anti-mouse CD45

  • APC/Fire™ 750 anti-mouse CD45

  • Brilliant Violet 750™ anti-mouse CD45

  • TotalSeq™-A0096 anti-mouse CD45

  • TotalSeq™-B0096 anti-mouse CD45

  • Ultra-LEAF™ Purified anti-mouse CD45

  • Spark Blue™ 550 anti-mouse CD45

  • Spark NIR™ 685 anti-mouse CD45

  • TotalSeq™-C0096 anti-mouse CD45

  • Spark YG™ 570 anti-mouse CD45

  • PE/Fire™ 640 anti-mouse CD45

  • APC/Fire™ 810 anti-mouse CD45

  • PE/Fire™ 700 anti-mouse CD45

  • Spark Violet™ 538 anti-mouse CD45

  • Spark YG™ 593 anti-mouse CD45

  • Spark Blue™ 574 anti-mouse CD45 Antibody

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account